Nick Havercroft is the founder of Bioneb. Latest round: Series D. Backed by Global Emerging Markets. Based in London, United Kingdom.
Nick Havercroft is the founder of BioNeb, a UK and China-based drug delivery formulation company. BioNeb develops pulmonary microdroplets using its patented Micron Micro Mesh technology, aiming to produce reproducible droplets for pharmacological applications, Nicotine Replacement Therapy, and recreational marijuana extracts. The company was founded in 2013 and has raised an undisclosed amount of funding, including a Series D round from Global Emerging Markets.
Full founder directory · Investor directory · Company funding database · Fundraising library